Addressing Palliative Care Needs Among Intensive Care Unit Family Members (ICUconnect)

July 13, 2022 updated by: Duke University
The quality of palliative care is highly variable for many patients treated in intensive care units (ICUs) and their family members. To address these challenges, the investigators will test the impact of a mobile app designed to help families navigate ICU-based palliative care vs. usual care. The investigators hypothesize that the intervention will reduce patient/family member unmet palliative care needs and improve the quality of clinical-family communication in racially/ethnically diverse populations.

Study Overview

Detailed Description

The quality of palliative care is highly variable in an intensive care unit (ICU) setting. These markers of poor quality are even more common among Black patients and families than among Whites. To address these challenges, the investigators developed a mobile app that allows families to both give and receive information relevant to palliative care and for ICU clinicians to visualize patient/family data and therefore better support them.

To determine the effect of this intervention,the investigators propose to conduct a randomized clinical trial (RCT) comparing the intervention to usual care to address four specific aims: (1) Using a cluster randomized clinical trial, determine the effect of the intervention vs usual care on unmet needs [as measured by the NEST scale], psychological distress symptoms [as measured by the PHQ-9, GAD-7, and PTSS scales], and patient-centered care [as measured by the IPC scale]; (2) Determine the impact of the intervention on unmet needs and patient-centered care based across different racial groups; and (3) Explore family member and clinician experiences with intervention using mixed methods to understand mechanisms within unique case contexts [exploratory aim]. The investigators hypothesize that compared to usual care, ICUconnect will reduce family members' unmet needs, reduce family member psychological distress, increase the patient-centeredness care, and reduce hospital length of stay overall--though the magnitude of effect will be greater among Blacks compared to Whites.

Study Type

Interventional

Enrollment (Actual)

111

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Durham, North Carolina, United States, 27710
        • Duke University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

PATIENTS

Inclusion Criteria:

  • ≥18 years of age
  • Receive mechanical ventilation in a study ICU for ≥48 hours under care of a study ICU physician

Exclusion Criteria (pre-consent):

  • Decisional capacity
  • Death expected within 24 hours
  • Admission to an ICU at the index hospital >14 days
  • Comfort care or withdrawal of treatment planned
  • Imprisoned
  • Extubated and possess decisional capacity prior to informed consent
  • Died before T2 survey complete
  • No known family or surrogate
  • Care assumed by a non-study ICU attending after consent by patient/family but before T1
  • Care assumed by non-study ICU attending <3 days after T1 but before T2
  • Study ICU attending physicians from different groups (i.e., intervention or control) caring for patient change <3 days after T1 completed by family

Exclusion Criteria (post-consent):

  • Patient regains decision making capacity before T2
  • Patient dies before T2

FAMILY MEMBER

Inclusion Criteria:

  • ≥18 years of age
  • Self-described as the individual (related or unrelated) who provides the most support and with whom the patient has a significant relationship (per definition of 'family' described in the Society of Critical Care Medicine 2016 Guidelines for Family-Centered Care in the Neonatal, Pediatric, and Adult ICU)

Exclusion Criteria (pre-consent):

  • Lack a knowledge of English such that the potential participant is not confident that they could complete study tasks (app viewing, surveys)
  • Imprisoned
  • Unable to complete surveys for any reason
  • Describe their race as neither White nor Black*
  • Describe their ethnicity as Hispanic*

    • Note that this study explicitly targets issues of racial disparities in healthcare, particularly of Black / African-Americans. Hispanics are excluded because of the pervasive nature of US residents' general belief that 'Hispanic' is a racial category.

Exclusion criteria (post-consent):

  • If the assigned randomized ICU attending physician either leaves ICU service or is replaced by a non-participating ICU physician <= 2 calendar days after family member completes T1 survey
  • Low need burden (NEST score <15)*

ICU PHYSICIANS

Inclusion Criteria:

  • ≥18 years of age
  • Attending physician in a study ICU

Exclusion Criteria:

- None

*The NEST score cutoff was changed on June 26, 2019. At this point, 3 patients had been randomized. This change was based on our review of data (NEST + psychological distress symptoms) from a parallel cohort study of >50 family members of ICU patients who met nearly identical eligibility criteria as for the ICUconnect trial. This was a larger cohort than the pilot study on which we based the NEST cutoff.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Mobile app group
Clinicians and family members will receive access to versions of the needs-focused mobile app that differ in content.
A mobile web app designed to assist both ICU clinicians in addressing patient/family needs and families in reporting their unmet needs.
PLACEBO_COMPARATOR: Usual care
Usual ICU care
Usual ICU care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Needs; Existential concerns; Symptoms; and Therapeutic interaction (NEST) scale total score
Time Frame: Time 1 (baseline), Time 2 (target ~3 days post-randomization), and Time 3 (target ~1 week post-randomization)
A palliative care needs instrument. Scores range from 0 (no needs) to 130 (higher needs)
Time 1 (baseline), Time 2 (target ~3 days post-randomization), and Time 3 (target ~1 week post-randomization)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Health Questionnaire 9-Item scale (PHQ-9)
Time Frame: Time 1 (baseline), Time 2 (target ~3 days post-randomization), and Time 4 (3 months post-randomization)
A depression symptoms instrument. Scores range from 0 (no depression symptoms) to 27 (higher depression symptoms)
Time 1 (baseline), Time 2 (target ~3 days post-randomization), and Time 4 (3 months post-randomization)
Generalized Anxiety Disorder 7-Item scale (GAD-7)
Time Frame: Time 1 (baseline), Time 2 (target ~3 days post-randomization), and Time 4 (3 months post-randomization)
An anxiety symptoms instrument. Scores range from 0 (no anxiety symptoms) to 21 (higher anxiety symptoms)
Time 1 (baseline), Time 2 (target ~3 days post-randomization), and Time 4 (3 months post-randomization)
Post-Traumatic Stress Symptom (PTSS) inventory
Time Frame: Time 1 (baseline) and Time 4 (3 months post-randomization)
A post-traumatic stress disorder symptom instrument. Scores range from 10 (low PTSD symptoms) to 70 (higher PTSD symptoms)
Time 1 (baseline) and Time 4 (3 months post-randomization)
Goal concordant care
Time Frame: Time 1 (baseline) and Time 2 (target ~3 days post-randomization)
A measure of the alignment between patient values and treatments received. This is a dichotomous scale; care is either concordant or discordant.
Time 1 (baseline) and Time 2 (target ~3 days post-randomization)
Post-randomization hospital length of stay
Time Frame: Across the entire hospitalization after randomization (approximately 2 weeks)
A measure of hospital days after randomization
Across the entire hospitalization after randomization (approximately 2 weeks)
Post-randomization intensive care unit length of stay
Time Frame: Across the entire hospitalization after randomization (approximately 2 weeks)
A measure of intensive care unit days after randomization
Across the entire hospitalization after randomization (approximately 2 weeks)
Interpersonal Processes of Care (IPC) 18-Item Short Form Scale
Time Frame: Baseline (at time of randomization) and ~3 days post-randomization
A measure of the interpersonal aspects of care. We will use the Communication (elicited concerns), Decision Making, and Discriminated due to race/ethnicity subscales. Scores will be evaluated primarily by subscales, though also a summary measure of these subscales.
Baseline (at time of randomization) and ~3 days post-randomization

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Christopher Cox, MD', Duke University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

April 10, 2019

Primary Completion (ACTUAL)

February 8, 2022

Study Completion (ACTUAL)

May 18, 2022

Study Registration Dates

First Submitted

April 9, 2018

First Submitted That Met QC Criteria

April 16, 2018

First Posted (ACTUAL)

April 24, 2018

Study Record Updates

Last Update Posted (ACTUAL)

July 15, 2022

Last Update Submitted That Met QC Criteria

July 13, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • Pro00090202
  • 1U54MD012530 (NIH)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critical Illness

Clinical Trials on Needs-focused mobile app

Subscribe